ABPI director general Dr Richard Barker is to step down in 2011 after six years at the helm of the …
Abbott has pulled its anti-obesity drug Meridia in the US after recent trials showed it increased the risk of stroke …
Cancer Research UK appoints Doctors.net to launch campaign to raise awareness of the charity’s vast information resources for GPs
Boehringer Ingelheim has discontinued development of its hypoactive sexual desire disorder drug Girosa after the FDA refused to approve it. …
Sanofi-Aventis is to cut a quarter of its workforce in the US – making 1,700 people redundant – as it …
Novartis will make use of a technology developed by Synthetic Genomics Vaccines, a new company set up by genomics pioneer …
Henry Featherstone has joined Fleishman-Hillard’s London healthcare public affairs and corporate communications team as a senior policy adviser. He moves …

Janssen UK has officially launched its new psoriasis disease awareness campaign, part of which includes the first pharma Facebook page …
The government’s plans to reform the NHS are moving too far according to health think tank the King’s Fund. Radical …
Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …
AstraZeneca is due to begin enrolling patients into a new study of its oral antiplatelet Brilique (ticagrelor) before the end …
A wise man once said: “The secret to surviving is knowing what to throw away and knowing what to keep.” …
NICE is to allow wider access to Alzheimer’s disease treatments, ending an epic five year battle for access to the …

Bracknell, UK-based Commercial services company 4Sight has made three high-level appointments. Jonathan Hartless (pictured) joins as operations director from an …

GlaxoSmithKline believes European regulators were wrong to withdraw its diabetes drug Avandia from the market, but will not challenge their …
NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …
GlaxoSmithKline has completed its review of a manufacturing facility in Ireland and concluded that it will have to shed 121 …
Pfizer is reviewing options for its drug delivery systems business Capsugel, including a possible sale of the unit. Pfizer has …
For doctors, the next 12 months will not only bring financial pressure and a raft of new health policies, it …

PAN is pleased to announce two new appointments and three promotions. Andisheh Thomson joins as Account Manager and Natalie Enniks …